US Stock MarketDetailed Quotes

Aptose Biosciences. Inc. (APTOF)

Watchlist
  • 1.570
  • -0.010-0.63%
15min DelayClose Jun 5 10:28 ET
4.01MMarket Cap-0.15P/E (TTM)

About Aptose Biosciences. Inc. Company

Aptose Biosciences, Inc. is a clinical-stage oncology company, which engages in the discovery, research, and development of anti-cancer therapies. Its product pipeline includes APTO-253, a small molecule that induces expression of the Kruppel-Like Factor 4 genes; and CG-806 a non-covalent small molecule therapeutic agent. The company was founded on September 5, 1986 and is headquartered in Toronto, Canada.

Company Profile

SymbolAPTOF
Company NameAptose Biosciences. Inc.
ISINCA03835T4081
Founded1986
CEODr. William G. Rice, PhD
MarketPink Market
Employees14
Fiscal Year Ends12-31
AddressTD Bank Tower,66 Wellington Street West,Suite 5300
CityToronto
ProvinceOntario
CountryCanada
Zip CodeM5K 1E6
Phone1-647-479-9828

Company Executives

  • Name
  • Position
  • Salary
  • Fletcher Payne
  • Senior Vice President, Chief Business Officer, Chief Financial Officer and Corporate Secretary
  • --
  • Dr. Rafael Bejar, M.D.,PhD
  • Senior Vice President and Chief Medical Officer
  • --
  • Dr. William G. Rice, PhD
  • Chairman of the Board, President and Chief Executive Office
  • --
  • Warren Whitehead
  • Independent Director
  • --
  • Dr. Mark D. Vincent, M.D.
  • Independent Director
  • --
  • Dr. Erich M. Platzer, M.D.,PhD
  • Independent Director
  • --
  • Dr. Denis R. Burger,PhD
  • Independent Director
  • --
  • Dr. Bernd R. Seizinger, M.D.,PhD
  • Independent Director
  • --
Market Insights
China Concept Stocks
View More
Middle East conflict spreads to the stock market! How should investors respond?
On June 3, Eastern Time, the U.S. House of Representatives passed a resolution limiting Trump's authority to use military force against Iran Show More